Innovative Cardiovascular Solutions
Total Raised
$22.34MDeal Terms
2Funding, Valuation & Revenue
7 Fundings
Innovative Cardiovascular Solutions's latest funding round was a Debt - II for $0.65M on January 3, 2022.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
1/3/2022 | Debt - II | $0.65M | Undisclosed Investors | 1 | ||
10/9/2020 | Unattributed | |||||
9/5/2018 | Series C | |||||
7/11/2017 | Series B | |||||
7/27/2015 | Series A |
Date | 1/3/2022 | 10/9/2020 | 9/5/2018 | 7/11/2017 | 7/27/2015 |
---|---|---|---|---|---|
Round | Debt - II | Unattributed | Series C | Series B | Series A |
Amount | $0.65M | ||||
Investors | Undisclosed Investors | ||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
Innovative Cardiovascular Solutions Deal Terms
2 Deal Terms
Innovative Cardiovascular Solutions's deal structure is available for 2 funding rounds, including their Series B from July 11, 2017.
Round | Series B | Series A |
---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.